{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-25-014656","form_type":"8-K","ticker":"BLCO","cik":"0001860742","company_name":"Bausch & Lomb Corp","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.857042+00:00","generated_at":"2026-05-16T20:36:00.182398+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Bausch + Lomb targets 5-7% revenue CAGR, ~23% EBITDA margin; pipeline peak sales ~$7B","bullets":["Targets 5-7% constant currency revenue CAGR 2025-2028.","Adjusted EBITDA margin (excl. Acq. IPR&D) target of ~23% in 2028.","Double-digit adjusted EPS growth (excl. Acq. IPR&D) expected 2026-2028.","Pipeline products projected peak sales of ~$7 billion; key launches include ELIOS MIGS (US 2H 2026) and PreserVision AREDS3 (1H 2026).","Net leverage target of ~3.5x by end of 2028; 2025 guidance reaffirmed."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-25-014656","json":"https://secwatch.observer/filing/0000950103-25-014656.json","markdown":"https://secwatch.observer/filing/0000950103-25-014656.md","text":"https://secwatch.observer/filing/0000950103-25-014656.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860742/000095010325014656/0000950103-25-014656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860742/000095010325014656/dp237254_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:36:00.182398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}